The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: Lessons from Sjögren's syndrome (autoimmune epithelitis)

Lupus

Volumn 15, Issue 5, 2006, Pages 255-261

  Mitsias, D I ^a   Kapsogeorgou, E K ^a   Moutsopoulos, H M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Antigen presenting cell; Apoptosis; Autoimmune epithelitis; Enterovirus (Coxsackie); Epithelial cell; Exosomes; Sj gren's syndrome

Indexed keywords

AUTOANTIGEN; CHEMOKINE; CYTOKINE;

ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNE DISEASE; CELL ACTIVATION; CELL FUNCTION; EPITHELIUM CELL; EXOCRINE GLAND; GERMINAL CENTER; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; LYMPHOCYTE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SJOEGREN SYNDROME; VIRUS INFECTION;

AUTOIMMUNE DISEASES; EPITHELIAL CELLS; HUMANS; MODELS, BIOLOGICAL; SJOGREN'S SYNDROME;

EID: 33744818170     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203306lu2290rr     Document Type: Review

References (62)

1. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren's syndrome. Arch Intern Med 2004; 164: 1275-1284.
2. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005; 165: 2337-2344.
3. Xanthou G, Tapinos NI, Polihronis M, Nezis IP, Margaritis LH, Moutsopoulos HM. CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjögren's syndrome. Clin Exp Immunol 1999; 118: 154-163.
4. Moutsopoulos HM. Sjogren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994; 72: 162-165.
5. Montoya MC, Sancho D, Vicente-Manzanares M, Sanchez-Madrid F. Cell adhesion and polarity during immune interactions. Immunol Rev 2002; 186: 68-82.
6. Moutsopoulos HM, Hooks JJ, Chan CC, Dalavanga YA, Skopouli FN, Detrick B. HLA-DR expression by labial minor salivary gland tissues in Sjögren's syndrome. Ann Rheum Dis 1986; 45: 677-683.
7. Manoussakis MN, Dimitriou ID, Kapsogeorgou EK et al. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome. Arthritis Rheum 1999; 42: 229-239.
8. Matsumura R, Umemiya K, Goto T, Nakazawa T et al. Glandular and extraglandular expression of costimulatory molecules in patients with Sjögren's syndrome. Ann Rheum Dis 2001; 60: 473-482.
9. Kapsogeorgou EK, Moutsopoulos HM, Manoussakis MN. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with CD28 receptor, but has reduced binding to CTLA4. J Immunol 2001; 166: 3107-3113.
10. Kapsogeorgou EK, Dimitriou ID, Abu-Helu RF et al. Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren's syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells. Clin Exp Immunol 2001; 124: 126-133.
11. Tsunawaki S, Nakamura S, Ohyama Y et al. Possible function of salivary gland epithelial cells as non professional antigen-presenting cells in the development of Sjögren's syndrome. J Rheumatol 2002; 29: 1884-1896.
12. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998; 16: 111-135.
13. Dimitriou ID, Kapsogeorgou EK, Moutsopoulos HM, Manoussakis M.N. CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation. Clin Exp Immunol 2002; 127: 386-392.
14. Ohlsson M, Szodoray P, Loro LL, Johannessen AC, Jonsson R. CD40, CD154, Bax and Bcl-2 expression in Sjögren's syndrome salivary glands: a putative anti-apoptotic role during its effector phases. Scand J Immunol 2002; 56: 561-571.
15. Spachidou MP, Bourazopoulou E, Kapsogeorgou EK et al. Functional Toll-like receptors (TLRs) are expressed by cultured salivary gland epithelial cells: increased mRNA expression of TLR-1, -2 and -4 in cells derived from patients with primary Sjögren's syndrome. Arthritis Rheum 2005; 52: 278 (abstract 684).
16. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335-376.
17. Boumba D, Skopouli FN, Moutsopoulos HM. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. Br J Rheumatol 1995; 34: 326-333.
18. Mitsias DI, Tzioufas AG, Veiopoulou C et al. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjögren's syndrome. Clin Exp Immunol 2002; 128: 562-568.
19. Moutsopoulos HM, Tzioufas AG, Bai MK, Papadopoulos NM, Papadimitriou CS. Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands. Ann Rheum Dis 1990; 49: 929-931.
20. Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C. Antigen driven clonal proliferation of B cells within the target tissue of an autoimmune disease: the salivary glands of patients with Sjögren's syndrome. J Clin Invest 1998; 102: 938-946.
21. Salomonsson S, Jonsson MV, Skarstein K et al. Cellular basis of ectopic germinal centre formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003; 48: 3187-3201.
22. Xanthou G, Polihronis M, Tzioufas AG, Paikos S, Sideras P, Moutsopoulos HM. "Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjogren's syndrome patients: possible participation in lymphoid structure formation. Arthritis Rheum 2001; 44: 408-418.
23. Salomonsson S, Larsson P, Tengner P, Mellquist E, Hjelmstrom P, Wahren-Herlenius M. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome. Scand J Immunol 2002; 55: 336-342.
24. Amft N, Curnow SJ, Scheel-Toellner D et al. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal centre-like structures in Sjögren's syndrome. Arthritis Rheum 2001; 44: 2633-2641.
25. Barone F, Bombardieri M, Manzo A et al. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome. Arthritis Rheum 2005; 52: 1773-1784.
26. Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma- inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. Arthritis Rheum 2002; 46: 2730-2741.
27. Groom J, Kalled SL, Cutler AH et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest 2002; 109: 59-68.
28. Thien M, Phan TG, Gardam S et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 2004; 20: 785-798.
29. Pers JO, Daridon C, Devauchelle V et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci 2005; 1050: 34-39.
30. Cuello C, Palladinetti P, Tedla N et al. Chemokine expression and leukocyte infiltration in Sjögren's syndrome. Br J Rheumatol 1998; 37: 779-783.
31. Vitali C, Bombardieri S, Jonsson R et al. European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-558.
32. Slobbe RL, Pluk W, van Venrooij WJ, Pruijn GJ. Ro ribonucleoprotein assembly in vitro. Identification of RNA-protein and protein-protein interactions. J Mol Biol 1992; 227: 361-366.
33. Fabini G, Rutjes SA, Zimmermann C, Pruijn GJ, and Steiner, G. Analysis of the molecular composition of Ro ribonucleoprotein complexes. Identification of novel Y RNA binding proteins. Eur J Biochem 2000; 267: 2778-2789.
34. Cheng ST, Nguyen TQ, Yang YS, Capra JD, Sontheimer RD. Calreticulin binds hYRNA and the 52-kDa polypeptide component of the Ro/SS-A ribonucleoprotein autoantigen. J Immunol 1996; 156: 4484-4491.
35. Fouraux MA, Bouvet P, Verkaart S, van Venrooij WJ, Pruijn GJ. Nucleolin associates with a subset of the human Ro ribonucleoprotein complexes. J Mol Biol 2002; 320: 475-488.
36. Polihronis M, Tapinos NI, Theocharis SE, Economou A, Kittas C, Moutsopoulos HM. Modes of epithelial cell death and repair in Sjögren's syndrome (SS). Clin Exp Immunol 1998; 114: 485-490.
37. Manganelli P, Fietta P. Apoptosis and Sjogren syndrome. Semin Arthritis Rheum 2003; 33: 49-65.
38. Kong L, Ogawa N, Nakabayashi T et al. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 1997; 40: 87-97.
39. Matsumura R, Umemiya K, Goto T et al. Interferon gamma and tumor necrosis factor alpha induce Fas expression and anti-Fas mediated apoptosis in a salivary ductal cell line. Clin Exp Rheumatol 1998; 16: 561-568.
40. Abu Helu RF, Dimitriou ID, Kapsogeorgou EK, Moutsopoulos HM, Manoussakis MN. Induction of salivary gland epithelial cell injury in Sjögren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression. J Autoimmun 2001; 17: 141-153.
41. Ping L, Ogawa N, Sugai S. Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren's syndrome. Arthritis Rheum 2005; 52: 573-581.
42. Fulda S, Debatin KM. IFN-γ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene 2002; 21: 2295-2308.
43. Kong L, Ogawa N, McGuff HS et al. Bcl-2 family expression in salivary glands from patients with primary Sjogren's syndrome: involvement of Bax in salivary gland destruction. Clin Immunol Immunopathol 1998; 88: 133-141.
44. Humphreys-Beher MG, Peck AB, Dang H, Talal N. The role of apoptosis in the initiation of the autoimmune response in Sjögren's syndrome. Clin Exp Immunol 1999; 116: 383-387.
45. Kong L, Robinson CP, Peck AB et al. Inappropriate apoptosis of salivary and lachrymal gland epithelium of immunodeficient NOD-scid mice. Clin Exp Rheumatol 1998; 16: 675-681.
46. Masao R, Aiba-Masago S, Talal N et al. Elevated pro-apoptotic Bax and caspase 3 activation in the NOD.scid model of Sjogren's syndrome. Arthritis Rheum 2001; 44: 693-702.
47. Martin SJ, Reutelingsperger CP, McGahon AJ et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182: 1545-1556.
48. McArthur C, Wang Y, Veno P, Zhang J, Fiorella R. Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly(ADP-ribose) polymerase and alpha-fodrin autoantigens during apoptosis in human salivary gland cells induced by tumour necrosis factor-alpha. Arch Oral Biol 2002; 47: 443-448.
49. Ohlsson M, Jonsson R, Brokstad KA. Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome. Scand J Immunol 2002; 56: 456-469.
50. McCluskey J, Farris AD, Keech CL et al. Determinant spreading: lessons from animal models and human disease. Immunol Rev 1998; 164: 209-229.
51. Keech CL, Gordon TP, McCluskey J. The immune response to 52-kDa Ro and 60-kDa Ro is linked in experimental autoimmunity. J Immunol 1996; 157: 3694-3699.
52. Sumida T, Matsumoto I, Maeda T, Nishioka K. T-cell receptor in Sjögren's syndrome. Br J Rheumatol 1997; 36: 622-629.
53. Ajjan RA, McIntosh RS, Waterman EA et al. Analysis of the T-cell receptor Valpha repertoire and cytokine gene expression in Sjogren's syndrome. Br J Rheumatol 1998; 37: 179-185.
54. Gottenberg JE, Busson M, Loiseau P et al. In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum 2003; 48: 2240-2245.
55. Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2: 569-579.
56. Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN. Salivary gland epithelial cell exosomes: A source of autoantigenic ribonucleoproteins. Arthritis Rheum 2005; 52: 1517-1521.
57. Haddad J, Deny P, Munz-Gotheil C et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-323.
58. Ohyama Y, Nakamura S, Hara H et al. Accumulation of human T lymphotropic virus type I-infected T cells in the salivary glands of patients with human T lymphotropic virus type I-associated Sjogren's syndrome. Arthritis Rheum 1998; 41: 1972-1978.
59. Talal N, Dauphinee MJ, Dang H, Alexander SS, Hart DJ, Garry RF. Detection of serum antibodies to retroviral proteins in patients with primary Sjogren's syndrome (autoimmune exocrinopathy). Arthritis Rheum 1990; 33: 774-781.
60. Scott CA, Avellini C, Desinan L et al. Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjogren's syndrome. Histopathology 1997; 30: 41-48.
61. Triantafyllopoulou A, Tapinos N, Moutsopoulos HM. Evidence for coxsackievirus infection in primary Sjögren's syndrome. Arthritis Rheum 2004; 50: 2897-2902.
62. Zinkernagel RM. Anti-infection immunity and autoimmunity. Ann N Y Acad Sci 2002; 958: 3-6.